Abstract |
|
Authors | Xue Yang, Huipeng Li, Chenggen Qian, Yuxin Guo, Chenzi Li, Fang Gao, Ying Yang, Kaikai Wang, David Oupicky, Minjie Sun |
Journal | Nanomedicine : nanotechnology, biology, and medicine
(Nanomedicine)
Vol. 14
Issue 7
Pg. 2283-2294
(10 2018)
ISSN: 1549-9642 [Electronic] United States |
PMID | 29981460
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2018 Elsevier Inc. All rights reserved. |
Chemical References |
- 2-(2-(2-chloro-3-((1,3-dihydro-3,3-dimethyl-1-propyl-2H-indol-2-ylidene)ethylidene)-1-cyclohexen-1-yl)ethenyl)-3,3-dimethyl-1-propylindolium
- Angiogenesis Inhibitors
- Drug Carriers
- Indoles
- Liposomes
- Sunitinib
|
Topics |
- Angiogenesis Inhibitors
(chemistry, pharmacology)
- Animals
- Apoptosis
- Breast Neoplasms
(pathology, therapy)
- Cell Movement
- Cell Proliferation
- Combined Modality Therapy
- Drug Carriers
(chemistry)
- Drug Delivery Systems
- Female
- Humans
- Hyperthermia, Induced
- Indoles
(administration & dosage, chemistry)
- Lasers
- Liposomes
(administration & dosage, chemistry)
- Mice
- Mice, Inbred BALB C
- Mice, Nude
- Neovascularization, Pathologic
(pathology, therapy)
- Phototherapy
- Spectroscopy, Near-Infrared
- Sunitinib
(chemistry, pharmacology)
- Tumor Cells, Cultured
- Xenograft Model Antitumor Assays
|